On today's episode we will be discussing specialty pharmacy with Dr. Ruchik Patel (Associate Director, Management Consulting at AESARA) and Dr. Sonalie Patel (Program Director & Clinical Pharmacist at Northwestern Medicine).

Time Stamps:

00:00 – 02:37 Introduction

02:38 – 10:03 Overview of Specialty Pharmacy and Discussion on its Role

10:04 – 12:22 Introduction and Discussion on the Role of Specialty Pharmacist

12:41 – 15:28 Discussion on Current Challenges Faced by Specialty Pharmacists

15:46 – 17:31 Response to Challenges in Specialty Pharmacy

17:40 – 22:14 Real-World Experiences and Evidence Sharing

22:31 – 24:55 Significance of Evidence Generation in Specialty Pharmacy

25:20 – 27:09 Discussion on Additional Gaps and Opportunities in Specialty Pharmacy

Episode Resources:

• Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C virus retreatment in decompensated cirrhosis (https://onlinelibrary.wiley.com/doi/10.1111/liv.15075)
• Sustained virologic response in DAA-treated HCV patients on anti-epileptic drugs (https://www.journal-of-hepatology.eu/article/S0168-8278(23)00347-1/fulltext)
• Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011907/)
• Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings (https://www.journal-of-hepatology.eu/article/S0168-8278(21)00158-6/fulltext)

Guest Bios:

• Ruchik Patel (https://www.linkedin.com/in/ruchiksp/)
• Sonalie Patel (https://www.linkedin.com/in/sonaliepatel/)